JP2010534684A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534684A5 JP2010534684A5 JP2010518431A JP2010518431A JP2010534684A5 JP 2010534684 A5 JP2010534684 A5 JP 2010534684A5 JP 2010518431 A JP2010518431 A JP 2010518431A JP 2010518431 A JP2010518431 A JP 2010518431A JP 2010534684 A5 JP2010534684 A5 JP 2010534684A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition according
- amino acid
- acid sequence
- cationic peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 125000002091 cationic group Chemical group 0.000 claims 6
- 230000000699 topical Effects 0.000 claims 1
Claims (8)
- 配列番号１、配列番号２、配列番号３、配列番号４、及び配列番号５からなる群から選択されるアミノ酸配列を含むカチオン性ペプチドを含む組成物。
- カチオン性ペプチドが配列番号１のアミノ酸配列からなる、請求項１に記載の組成物。
- カチオン性ペプチドが配列番号２のアミノ酸配列からなる、請求項１に記載の組成物。
- カチオン性ペプチドが配列番号３のアミノ酸配列からなる、請求項１に記載の組成物。
- カチオン性ペプチドが配列番号４のアミノ酸配列からなる、請求項１に記載の組成物。
- カチオン性ペプチドが配列番号５のアミノ酸配列からなる、請求項１に記載の組成物。
- 局所用組成物である、請求項２〜６のいずれかに記載の組成物。
- 請求項２〜７のいずれかに記載の組成物とディスペンサーとを含む、組成物投与用キット。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95205907P | 2007-07-26 | 2007-07-26 | |
| US60/952,059 | 2007-07-26 | ||
| PCT/US2008/071350 WO2009015385A1 (en) | 2007-07-26 | 2008-07-28 | Antimicrobial peptide, compositions , and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013222846A Division JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010534684A JP2010534684A (ja) | 2010-11-11 |
| JP2010534684A5 true JP2010534684A5 (ja) | 2011-06-02 |
| JP5401457B2 JP5401457B2 (ja) | 2014-01-29 |
Family
ID=40281862
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518431A Expired - Fee Related JP5401457B2 (ja) | 2007-07-26 | 2008-07-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2013222846A Expired - Fee Related JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2016132290A Pending JP2017002057A (ja) | 2007-07-26 | 2016-07-04 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2018153719A Active JP6722241B2 (ja) | 2007-07-26 | 2018-08-17 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2020105975A Pending JP2020169190A (ja) | 2007-07-26 | 2020-06-19 | 抗菌ペプチド、組成物及びその使用方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013222846A Expired - Fee Related JP5965884B2 (ja) | 2007-07-26 | 2013-10-28 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2016132290A Pending JP2017002057A (ja) | 2007-07-26 | 2016-07-04 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2018153719A Active JP6722241B2 (ja) | 2007-07-26 | 2018-08-17 | 抗菌ペプチド、組成物及びその使用方法 |
| JP2020105975A Pending JP2020169190A (ja) | 2007-07-26 | 2020-06-19 | 抗菌ペプチド、組成物及びその使用方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8623811B2 (ja) |
| EP (3) | EP3741380A1 (ja) |
| JP (5) | JP5401457B2 (ja) |
| KR (4) | KR101717275B1 (ja) |
| CN (2) | CN102872447B (ja) |
| AU (1) | AU2008278593B2 (ja) |
| BR (3) | BRPI0813627B1 (ja) |
| CA (1) | CA2694046C (ja) |
| CO (1) | CO6260098A2 (ja) |
| CR (1) | CR11239A (ja) |
| CY (2) | CY1118503T1 (ja) |
| DK (2) | DK3120862T3 (ja) |
| ES (2) | ES2805225T3 (ja) |
| HK (1) | HK1180237A1 (ja) |
| HR (1) | HRP20161722T1 (ja) |
| HU (1) | HUE031136T2 (ja) |
| IL (3) | IL203173A (ja) |
| LT (1) | LT2178549T (ja) |
| MX (1) | MX2010000916A (ja) |
| NZ (1) | NZ582459A (ja) |
| PL (1) | PL2178549T3 (ja) |
| PT (2) | PT3120862T (ja) |
| SG (1) | SG188128A1 (ja) |
| SI (1) | SI2178549T1 (ja) |
| WO (1) | WO2009015385A1 (ja) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009007070A (es) * | 2006-12-29 | 2009-07-10 | Revance Therapeutics Inc | Moleculas de transporte que utilizan los polipeptidos hiv-tat de secuencia inversa. |
| KR101717275B1 (ko) * | 2007-07-26 | 2017-03-16 | 레반스 테라퓨틱스, 아이엔씨. | 항미생물 펩티드, 조성물, 및 이용 방법 |
| US8933013B2 (en) | 2007-12-05 | 2015-01-13 | Nono Inc. | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| US8080518B2 (en) * | 2007-12-05 | 2011-12-20 | Arbor Vita Corporation | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| EP3556770A1 (en) | 2008-03-14 | 2019-10-23 | Allergan, Inc. | Immuno-based botulinum toxin serotype a activity assays |
| NO2379104T3 (ja) * | 2008-12-31 | 2018-07-28 | ||
| KR101959234B1 (ko) * | 2009-04-01 | 2019-03-18 | 레반스 테라퓨틱스, 아이엔씨. | 혈관 과민반응과 관련된 피부질환을 치료하기 위한 방법 및 조성물 |
| JP6043627B2 (ja) | 2009-06-25 | 2016-12-14 | ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | アルブミン非含有ボツリヌス毒素製剤 |
| US8387798B1 (en) | 2012-04-27 | 2013-03-05 | Abdulmohsen E. A. H. Al-Terki | Mutiple oral and nasal surgical procedures method and kit |
| US10022083B2 (en) | 2011-06-02 | 2018-07-17 | Abdulmohsen E. A. H. Al-Terki | Multiple oral and nasal surgical procedures method and kit |
| FR2997304B1 (fr) | 2012-10-26 | 2017-07-07 | Isp Investments Inc | Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens |
| US20140120077A1 (en) | 2012-10-28 | 2014-05-01 | Revance Therapeutics, Inc. | Compositions and Methods for Safe Treatment of Rhinitis |
| US20140242110A1 (en) * | 2013-02-28 | 2014-08-28 | Dt Scimed, Llc | Dose, localization, and formulation of botulinum toxins in skin and muscle |
| US11484580B2 (en) | 2014-07-18 | 2022-11-01 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
| US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| RU2728682C2 (ru) * | 2015-09-17 | 2020-07-31 | Контрафект Корпорейшн | Применение лизина для восстановления/увеличения антибактериальной активности антибиотиков в присутствии легочного сурфактанта, который ингибирует указанные антибиотики |
| US10105381B2 (en) * | 2016-05-23 | 2018-10-23 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US10144767B2 (en) * | 2016-08-18 | 2018-12-04 | Board Of Regents Of The University Of Nebraska | Anti-microbial peptides and coatings |
| MX2019005833A (es) * | 2016-11-21 | 2019-10-30 | Eirion Therapeutics Inc | Administracion transdermica de agentes grandes. |
| WO2019046311A1 (en) | 2017-08-28 | 2019-03-07 | Revance Therapeutics, Inc. | TRANSMUCOSAL COMPOSITIONS OF BOTULINUM TOXIN, KITS AND METHODS FOR TREATING BLADDER DISORDERS |
| CN107556374B (zh) * | 2017-08-30 | 2020-02-07 | 四川大学 | 唾液富脯蛋白仿生防龋功能多肽、其衍生物和盐及其应用 |
| CN107353334B (zh) * | 2017-08-30 | 2020-02-07 | 四川大学 | 基于唾液富酪蛋白的仿生防龋多肽、其衍生物和盐及应用 |
| JP7266202B2 (ja) * | 2018-02-19 | 2023-04-28 | 株式会社ファンケル | 化粧料及び抗炎症剤 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744166A (en) * | 1989-02-25 | 1998-04-28 | Danbiosyst Uk Limited | Drug delivery compositions |
| US5804604A (en) * | 1989-12-21 | 1998-09-08 | Biogen, Inc. | Tat-derived transport polypeptides and fusion proteins |
| US5674980A (en) * | 1989-12-21 | 1997-10-07 | Biogen Inc | Fusion protein comprising tat-derived transport moiety |
| WO1993021941A1 (en) | 1992-04-23 | 1993-11-11 | Allelix Biopharmaceuticals Inc. | Treatment of herpesvirus infection |
| DK0656950T3 (da) | 1992-08-21 | 1999-07-19 | Biogen Inc | TAT-afledte transportpolypeptider |
| CA2152373C (en) | 1993-10-22 | 1998-12-15 | Michael Twist (Deceased) | Treatment of cytomegalovirus infection |
| DE69434535T2 (de) | 1993-12-28 | 2006-07-20 | Allergan, Inc., Irvine | Toxische Komponente der Botulinumtoxine zur Modulation cholinergisch kontrollierter Sekretionen |
| US6232295B1 (en) | 1994-10-12 | 2001-05-15 | Jon Faiz Kayyem | Cell-specific contrast agent and gene delivery vehicles |
| GB9508204D0 (en) * | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
| ES2316154T3 (es) * | 1995-08-23 | 2009-04-01 | University Of British Columbia | Peptidos cationicos antimicrobianos y procedimientos de seleccion de los mismos. |
| US6043218A (en) * | 1996-10-22 | 2000-03-28 | Medical University Of South Carolina | Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
| GB9623051D0 (en) | 1996-11-06 | 1997-01-08 | Schacht Etienne H | Delivery of DNA to target cells in biological systems |
| AU1818299A (en) * | 1997-12-10 | 1999-06-28 | Washington University | Anti-pathogen system and methods of use thereof |
| AU751259B2 (en) * | 1997-12-12 | 2002-08-08 | Onyx Pharmaceuticals, Inc. | Selective killing and diagnosis of p53+ neoplastic cells |
| AU1706400A (en) | 1998-10-27 | 2000-05-15 | Mayo Foundation For Medical Education And Research | Methods for enhancing wound healing |
| EP1137664A2 (en) | 1998-12-10 | 2001-10-04 | Washington University | Protein transduction system and methods of use thereof |
| JP2002533379A (ja) | 1998-12-23 | 2002-10-08 | イデア アクチェンゲゼルシャフト | 生体内における局所的に非侵襲性である用途のための改善された製剤 |
| US7056656B1 (en) * | 1999-01-25 | 2006-06-06 | University Of Medicine And Dentistry Of New Jersey | Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA |
| US20030236214A1 (en) * | 1999-06-09 | 2003-12-25 | Wolff Jon A. | Charge reversal of polyion complexes and treatment of peripheral occlusive disease |
| US7008924B1 (en) * | 1999-07-21 | 2006-03-07 | Amgen, Inc. | VGF fusion polypeptides |
| US6669951B2 (en) | 1999-08-24 | 2003-12-30 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| US6544548B1 (en) * | 1999-09-13 | 2003-04-08 | Keraplast Technologies, Ltd. | Keratin-based powders and hydrogel for pharmaceutical applications |
| US6844324B1 (en) * | 1999-11-12 | 2005-01-18 | Massachusetts Institute Of Technology | Modular peptide mediated intracellular delivery system and uses therefore |
| US20030118598A1 (en) * | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
| US6670322B2 (en) * | 2000-06-01 | 2003-12-30 | Wisconsin Alumni Research Foundation | Method of targeting pharmaceuticals to motor neurons |
| US20030215412A1 (en) * | 2000-07-21 | 2003-11-20 | Essentia Biosystems, Inc. | Induction of hair growth with vascular endothelial growth factor |
| CA2797652C (en) * | 2000-07-21 | 2016-03-08 | Revance Therapeutics, Inc. | Multi-component biological transport systems |
| US20040220100A1 (en) * | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
| US6696038B1 (en) * | 2000-09-14 | 2004-02-24 | Expression Genetics, Inc. | Cationic lipopolymer as biocompatible gene delivery agent |
| US20020127247A1 (en) * | 2000-11-17 | 2002-09-12 | Allergen Sales, Inc. | Modified clostridial neurotoxins with altered biological persistence |
| DE60233137D1 (de) | 2001-02-16 | 2009-09-10 | Univ R | Transporter mit beabstandeten arginin-teilchen |
| CA2446458A1 (en) * | 2001-05-09 | 2002-11-14 | Yale University | Toll/interleukin-1 receptor adaptor protein (tirap) |
| US7060498B1 (en) * | 2001-11-28 | 2006-06-13 | Genta Salus Llc | Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| EP1461084A2 (en) * | 2001-12-11 | 2004-09-29 | The Board Of Trustees Of The Leland Stanford Junior University | Guanidinium transport reagents and conjugates |
| AU2003216389A1 (en) | 2002-02-21 | 2003-09-09 | Essentia Biosystems, Inc. | Induction of hair growth with vascular endothelial growth factor |
| US20030215395A1 (en) * | 2002-05-14 | 2003-11-20 | Lei Yu | Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| US20040009180A1 (en) | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
| JP4154218B2 (ja) * | 2002-11-27 | 2008-09-24 | 寛紀 高麗 | 新規抗菌性ポリペプチドとその利用 |
| IL153557A0 (en) * | 2002-12-19 | 2003-07-06 | Yitzchak Hillman | Antibodies and antagonists to antimicrobial peptides for the purpose of treating, inhibiting and preventing auto immune diseases |
| NZ540506A (en) | 2002-12-19 | 2008-09-26 | Yitzchak Hillman | Disease treatment via antimicrobial peptide inhibitors |
| BRPI0407058A (pt) * | 2003-02-01 | 2006-01-17 | Neuralab Ltd | Métodos de profilaxia e de tratamento de uma doença, composição farmacêutica, e, uso de um fragmento |
| WO2004084805A2 (en) * | 2003-03-19 | 2004-10-07 | The J. David Gladstone Institutes | Acetylated tat polypeptides and methods of use thereof |
| US7125842B2 (en) * | 2003-04-07 | 2006-10-24 | Canbas Co. Ltd. | Anti-fungal compounds and methods of use |
| CN1901933A (zh) * | 2003-09-12 | 2007-01-24 | 英属哥伦比亚大学 | 用阳离子肽刺激先天免疫的方法 |
| JP2005120050A (ja) * | 2003-10-20 | 2005-05-12 | Toagosei Co Ltd | 新規抗菌性ペプチドとその利用 |
| US8092788B2 (en) | 2004-03-03 | 2012-01-10 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| PT1729821E (pt) | 2004-03-03 | 2013-10-23 | Revance Therapeutics Inc | Composições e métodos para aplicação tópica e administração transdérmica de toxinas botulínicas |
| EP1927597B1 (en) * | 2004-08-18 | 2016-11-02 | Novabiotics Limited | Antibacterial peptides |
| EP1656951A1 (en) * | 2004-11-12 | 2006-05-17 | Xigen S.A. | Conjugates with enhanced cell uptake activity |
| EP2116603A3 (en) | 2004-11-12 | 2010-02-17 | The University Of British Columbia | Antimicrobial peptides |
| EP1661912A1 (en) | 2004-11-29 | 2006-05-31 | Xigen S.A. | Fusion protein comprising a BH3-domain of a BH3-only protein |
| JP4730584B2 (ja) * | 2004-12-06 | 2011-07-20 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
| JP2006238751A (ja) * | 2005-03-02 | 2006-09-14 | Toagosei Co Ltd | ベロ毒素結合性を有する抗菌ペプチド及びその利用 |
| EP1861112A4 (en) | 2005-03-03 | 2009-07-22 | Revance Therapeutics Inc | COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS |
| JP2008531725A (ja) | 2005-03-03 | 2008-08-14 | ルバンス セラピュティックス インク． | オリゴペプチドの局所適用及び経皮送達のための組成物及び方法 |
| CA2600384C (en) | 2005-03-30 | 2016-08-30 | Revance Therapeutics, Inc. | Compositions and methods for treating acne |
| NZ568216A (en) | 2005-11-17 | 2012-09-28 | Revance Therapeutics Inc | Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| US20080233152A1 (en) | 2006-12-29 | 2008-09-25 | Revance Therapeutics, Inc. | Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabilized with Polypeptide Fragments Derived from HIV-TAT |
| MX2009007070A (es) | 2006-12-29 | 2009-07-10 | Revance Therapeutics Inc | Moleculas de transporte que utilizan los polipeptidos hiv-tat de secuencia inversa. |
| KR101717275B1 (ko) * | 2007-07-26 | 2017-03-16 | 레반스 테라퓨틱스, 아이엔씨. | 항미생물 펩티드, 조성물, 및 이용 방법 |
| NO2379104T3 (ja) | 2008-12-31 | 2018-07-28 |
-
2008
- 2008-07-28 KR KR1020157019647A patent/KR101717275B1/ko active IP Right Grant
- 2008-07-28 SI SI200831732T patent/SI2178549T1/sl unknown
- 2008-07-28 EP EP20166266.5A patent/EP3741380A1/en active Pending
- 2008-07-28 KR KR1020177002763A patent/KR20170016031A/ko not_active Application Discontinuation
- 2008-07-28 NZ NZ582459A patent/NZ582459A/en unknown
- 2008-07-28 CN CN201210375756.5A patent/CN102872447B/zh active Active
- 2008-07-28 DK DK16184094.7T patent/DK3120862T3/da active
- 2008-07-28 HU HUE08826608A patent/HUE031136T2/en unknown
- 2008-07-28 JP JP2010518431A patent/JP5401457B2/ja not_active Expired - Fee Related
- 2008-07-28 LT LTEP08826608.5T patent/LT2178549T/lt unknown
- 2008-07-28 KR KR1020187007958A patent/KR102088949B1/ko active IP Right Grant
- 2008-07-28 KR KR1020107003133A patent/KR101722038B1/ko active IP Right Grant
- 2008-07-28 SG SG2013009832A patent/SG188128A1/en unknown
- 2008-07-28 BR BRPI0813627-0A patent/BRPI0813627B1/pt active IP Right Grant
- 2008-07-28 CN CN200880100641.7A patent/CN101842107B/zh active Active
- 2008-07-28 DK DK08826608.5T patent/DK2178549T3/en active
- 2008-07-28 BR BR122019000266-5A patent/BR122019000266B1/pt active IP Right Grant
- 2008-07-28 US US12/669,705 patent/US8623811B2/en active Active
- 2008-07-28 MX MX2010000916A patent/MX2010000916A/es active IP Right Grant
- 2008-07-28 ES ES16184094T patent/ES2805225T3/es active Active
- 2008-07-28 PT PT161840947T patent/PT3120862T/pt unknown
- 2008-07-28 EP EP08826608.5A patent/EP2178549B1/en active Active
- 2008-07-28 EP EP16184094.7A patent/EP3120862B1/en active Active
- 2008-07-28 PL PL08826608T patent/PL2178549T3/pl unknown
- 2008-07-28 WO PCT/US2008/071350 patent/WO2009015385A1/en active Application Filing
- 2008-07-28 PT PT88266085T patent/PT2178549T/pt unknown
- 2008-07-28 BR BR122019000258-4A patent/BR122019000258B1/pt active IP Right Grant
- 2008-07-28 CA CA2694046A patent/CA2694046C/en active Active
- 2008-07-28 ES ES08826608.5T patent/ES2609914T3/es active Active
- 2008-07-28 AU AU2008278593A patent/AU2008278593B2/en active Active
-
2010
- 2010-01-06 IL IL203173A patent/IL203173A/en active IP Right Grant
- 2010-01-27 CR CR11239A patent/CR11239A/es not_active Application Discontinuation
- 2010-02-26 CO CO10023449A patent/CO6260098A2/es not_active Application Discontinuation
-
2012
- 2012-12-20 IL IL223784A patent/IL223784A/en active IP Right Grant
- 2012-12-20 IL IL223785A patent/IL223785A/en active IP Right Grant
-
2013
- 2013-06-28 HK HK13107613.7A patent/HK1180237A1/zh unknown
- 2013-10-28 JP JP2013222846A patent/JP5965884B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-04 JP JP2016132290A patent/JP2017002057A/ja active Pending
- 2016-12-14 CY CY20161101296T patent/CY1118503T1/el unknown
- 2016-12-14 HR HRP20161722TT patent/HRP20161722T1/hr unknown
-
2018
- 2018-08-17 JP JP2018153719A patent/JP6722241B2/ja active Active
-
2020
- 2020-06-19 JP JP2020105975A patent/JP2020169190A/ja active Pending
- 2020-07-27 CY CY20201100692T patent/CY1123176T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534684A5 (ja) | ||
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2011136981A5 (ja) | ||
| JP2017048194A5 (ja) | ||
| JP2013507132A5 (ja) | ||
| JP2013172734A5 (ja) | ||
| JP2012034696A5 (ja) | ||
| JP2007045829A5 (ja) | ||
| JP2012126742A5 (ja) | ||
| JP2015513533A5 (ja) | ||
| JP2010088434A5 (ja) | ||
| JP2009504138A5 (ja) | ||
| JP2006006329A5 (ja) | ||
| JP2013510581A5 (ja) | ||
| JP2011155981A5 (ja) | ||
| DE602005008996D1 (de) | Radiofluorierte peptide | |
| JP2009225798A5 (ja) | ||
| WO2007149542A3 (en) | Antimicrobial kinocidin compositions and methods of use | |
| WO2007122581A3 (en) | Compositions and kits of phenylephrine | |
| NZ612161A (en) | Radiolabled her2 binding peptides | |
| EP2039366A4 (en) | COMPOSITION CONTAINING PEPTIDE AS ACTIVE INGREDIENT | |
| WO2008011335A3 (en) | Metal binding compounds, metal binding compositions, and their uses | |
| EA201001014A1 (ru) | Фармацевтически приемлемые соли метил (3-{[[3-(6-амино-2-бутокси-8-оксо-7,8-дигидро-9h-пурин-9-ил)пропил](3-морфолин-4-илпропил)амино]метил}фенил)ацетата и их применение в терапии | |
| WO2008093058A3 (en) | Peptides and their use | |
| JP2013539454A5 (ja) |